StonvexLoading…
StonvexStonvexStonvexCore line items from JBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $222.70M | $884.20M | $657.90M | $438.60M |
Operating Income | $13.10M | $111.50M | $90.70M | $61.30M |
Net Income | $200.00K | $53.80M | $46.70M | $20.70M |
EPS (Diluted) | $0.00 | $0.38 | $0.33 | $0.22 |
Total Assets | $1.31B | $1.30B | $1.30B | $1.30B |
Total Liabilities | $749.00M | $732.50M | $739.70M | $758.70M |
Cash & Equivalents | $112.00M | $194.40M | $178.90M | $173.60M |
Free Cash Flow OCF − CapEx | $33.40M | $114.00M | $94.80M | $86.50M |
Shares Outstanding | 138.77M | 139.74M | 139.90M | 140.14M |